Utah Medical Products
UTMD
117 hedge funds and large institutions have $118M invested in Utah Medical Products in 2025 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 50 reducing their positions, and 9 closing their positions.
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
0% more funds holding
Funds holding: 117 → 117 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.09% less ownership
Funds ownership: 67.62% → 65.54% (-2.1%)
14% less capital invested
Capital invested by funds: $136M → $118M (-$18.9M)
34% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 50
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$776K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$635K |
| 3 |
Goldman Sachs
New York
|
+$342K |
| 4 |
BlackRock
New York
|
+$273K |
| 5 |
EHC
Everett Harris & Co
Los Angeles,
California
|
+$241K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IP
Isthmus Partners
Madison,
Wisconsin
|
-$1.68M |
| 2 |
Morgan Stanley
New York
|
-$788K |
| 3 |
HCM
Huber Capital Management
El Segundo,
California
|
-$638K |
| 4 |
Bank of New York Mellon
New York
|
-$579K |
| 5 |
Renaissance Technologies
New York
|
-$423K |
UTMD Hedge Fund Activity: Q4 2025 in Review
117 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2025, worth a combined $118M — down 14% from $136M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new UTMD positions and 9 closed out — a net gain of 1 holder — while 33 added to existing stakes and 50 trimmed.
The largest buyer was Brandes Investment Partners, adding an estimated $776K. The largest seller was Isthmus Partners, cutting an estimated $1.68M.
- 117 institutional investors held Utah Medical Products (UTMD) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $118M of Utah Medical Products stock for Q4 2025, down 14% quarter-over-quarter.
- 10 funds opened new Utah Medical Products positions in Q4 2025 and 9 closed out, a net change of +1 holder.
- The largest Utah Medical Products buyer in Q4 2025 was Brandes Investment Partners, an estimated $776K added.
- The largest Utah Medical Products seller in Q4 2025 was Isthmus Partners, an estimated $1.68M sold.
Based on aggregated 13F filings for Q4 2025.